Literature DB >> 16000716

Effect of static growth and different levels of environmental oxygen on toxA and ptxR expression in the Pseudomonas aeruginosa strain PAO1.

Jennifer M Gaines1, Nancy L Carty1, Jane A Colmer-Hamood1, Abdul N Hamood1.   

Abstract

Within certain infection sites, such as the lung of cystic fibrosis patients, Pseudomonas aeruginosa grows statically under either decreased oxygen tension or anaerobic conditions, a situation that is likely to influence the production of virulence factors. The goal of this study was to determine the effect of static growth under microaerobic (decreased oxygen) and anaerobic conditions on the expression of the P. aeruginosa exotoxin A (ETA) gene toxA and its positive regulator ptxR. Using toxA-lacZ and ptxR-lacZ fusion plasmids, the level of toxA and ptxR expression was measured throughout the growth cycle of strain PAO1, which was grown in either iron-deficient or iron-sufficient medium under four different conditions: 20%-SH (aerobic, shaking), 20%-ST (aerobic, static), 10%-ST (microaerobic, static) and 0%-ST (anaerobic, static). In iron-deficient medium, toxA expression was higher under 20%-ST and 10%-ST than under 20%-SH. However, the highest level of toxA expression occurred under 0%-ST. Analysis of ETA protein using sandwich ELISA revealed that at time points between 8 and 24 h of the growth curve, PAO1 produced higher levels of ETA under 0%-ST than under 20%-SH. In iron-sufficient medium, toxA expression was significantly repressed under all conditions. Additional analyses using PAO1 strains that carry lacZ fusions with the toxA regulatory genes regA and pvdS revealed that the expression of regA and pvdS is reduced rather than increased at 0%-ST. ptxR expression under different conditions paralleled that of toxA expression, except that it was repressed by iron under 20 %-SH only. Between 6 and 24 h of growth, and under all conditions, the level of dissolved oxygen (DO) within the PAO1 cultures was sharply reduced. These results suggest that (1) the combined effect of static growth and anaerobic conditions produce a significant increase in toxA and ptxR expression in PAO1; (2) this effect appears to be unique to toxA and ptxR, since the level of regA and pvdS expression was reduced under the same conditions; (3) neither static growth nor anaerobic conditions interfere with the repression of toxA expression by iron, although static growth deregulates ptxR expression with respect to iron; and (4) the enhanced expression of toxA and ptxR is not related to the reduced levels of DO in PAO1 cultures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000716     DOI: 10.1099/mic.0.27754-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.956


  12 in total

1.  Full virulence of Pseudomonas aeruginosa requires OprF.

Authors:  Laurène Fito-Boncompte; Annelise Chapalain; Emeline Bouffartigues; Hichem Chaker; Olivier Lesouhaitier; Gwendoline Gicquel; Alexis Bazire; Amar Madi; Nathalie Connil; Wilfried Véron; Laure Taupin; Bertrand Toussaint; Pierre Cornelis; Qing Wei; Koki Shioya; Eric Déziel; Marc G J Feuilloley; Nicole Orange; Alain Dufour; Sylvie Chevalier
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

2.  Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection.

Authors:  Fabrizia Minandri; Francesco Imperi; Emanuela Frangipani; Carlo Bonchi; Daniela Visaggio; Marcella Facchini; Paolo Pasquali; Alessandra Bragonzi; Paolo Visca
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

3.  Serum albumin alters the expression of iron-controlled genes in Pseudomonas aeruginosa.

Authors:  Cassandra Kruczek; Mitchell Wachtel; Magdy S Alabady; Paxton R Payton; Jane A Colmer-Hamood; Abdul N Hamood
Journal:  Microbiology       Date:  2011-11-03       Impact factor: 2.777

4.  Bile Salts Differentially Enhance Resistance of Enterohemorrhagic Escherichia coli O157:H7 to Host Defense Peptides.

Authors:  Crystal Gadishaw-Lue; Alyssa Banaag; Sarah Birstonas; Aju-Sue Francis; Debora Barnett Foster
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

5.  Mucin inhibits Pseudomonas aeruginosa biofilm formation by significantly enhancing twitching motility.

Authors:  Cecily L Haley; Cassandra Kruczek; Uzma Qaisar; Jane A Colmer-Hamood; Abdul N Hamood
Journal:  Can J Microbiol       Date:  2014-01-24       Impact factor: 2.419

6.  Static Growth Promotes PrrF and 2-Alkyl-4(1H)-Quinolone Regulation of Type VI Secretion Protein Expression in Pseudomonas aeruginosa.

Authors:  Luke K Brewer; Weiliang Huang; Brandy J Hackert; Maureen A Kane; Amanda G Oglesby
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

7.  Norepinephrine represses the expression of toxA and the siderophore genes in Pseudomonas aeruginosa.

Authors:  Wang Li; Mark Lyte; Primrose P Freestone; Aziba Ajmal; Jane A Colmer-Hamood; Abdul N Hamood
Journal:  FEMS Microbiol Lett       Date:  2009-07-27       Impact factor: 2.820

8.  Role of Vfr in regulating exotoxin A production by Pseudomonas aeruginosa.

Authors:  Marko Davinic; Nancy L Carty; Jane A Colmer-Hamood; Michael San Francisco; Abdul N Hamood
Journal:  Microbiology (Reading)       Date:  2009-04-23       Impact factor: 2.956

9.  Serum influences the expression of Pseudomonas aeruginosa quorum-sensing genes and QS-controlled virulence genes during early and late stages of growth.

Authors:  Cassandra Kruczek; Uzma Qaisar; Jane A Colmer-Hamood; Abdul N Hamood
Journal:  Microbiologyopen       Date:  2014-02       Impact factor: 3.139

10.  The extra-cytoplasmic function sigma factor sigX modulates biofilm and virulence-related properties in Pseudomonas aeruginosa.

Authors:  Gwendoline Gicquel; Emeline Bouffartigues; Manjeet Bains; Virginie Oxaran; Thibaut Rosay; Olivier Lesouhaitier; Nathalie Connil; Alexis Bazire; Olivier Maillot; Magalie Bénard; Pierre Cornelis; Robert E W Hancock; Alain Dufour; Marc G J Feuilloley; Nicole Orange; Eric Déziel; Sylvie Chevalier
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.